ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inhibitory Potential of Shen-Shuai-Ling Formulation on Renal Interstitial Fibrosis via Upregulation of PLZF

Song, Na; Tu, Haitao; Li, Ying*; Xiong, Weijian; Zhang, Ling; Liu, Hong; Ding, Weisen; Long, Mei; Ren, Dewei; Zhong, Jin广州中医药大学; 1; y
Evidence-based Complementary and Alternative Medicine2022-3-31DOI: 10.1155/2022/5967804
9阅读
引用收藏
分享

摘要

Background. Renal interstitial fibrosis (RIF) is an important cause of kidney disease, which seriously affects people's health. As a traditional Chinese medicine, Shen-Shuai-Ling Formulation (SSLF) has obvious kidney function. However, the therapeutic effect of SSLF on RIF and its molecular mechanism are still unclear. Methods. First, the potential targets and pathways of SSLF for RIF were predicted by network pharmacology, and then, the binding of luteolin and target protein to SSLF was verified by molecular docking and Co-IP experiments. Finally, the effects of SSLF and luteolin on PLZF and (Pro) renin receptor (PRR) were verified by western blot and qPCR experiments. Angiotensin (Ang)-1, Ang-2, and transforming growth factor-beta (TGF-beta) were the indexes of renal interstitial fibrosis. Results. Through the drug-active component-target network diagram, we found that luteolin has the most connections, and promyelocytic leukemia zinc finger (PLZF) is the target protein. GO analysis and KEGG pathway analysis of targets were performed using Cytoscape ClueGO. Molecular docking experiments and Co-IP are used to prove that luteolin and PLZF can be combined. Western blot and qPCR results showed that both SSLF and luteolin significantly upregulated the expression of PLZF and decreased the levels of PRR, Ang-1, Ang-2, and TGF-beta. The overexpression of PLZF decreased the expression of PRR, the knockdown of PLZF increased the expression of PRR, and the overexpression of PRR decreased the expression of Ang-1, Ang-2, and TGF-beta. Conclusions. SSLF inhibits PRR and renal interstitial fibers by the upregulation of PLZF levels.

学科与关键词

关键词
(PRO)RENIN RECEPTORANGIOTENSIN-IITGF-BETANEPHROPATHY
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2022-03-31
卷期
第 2022 卷
页码
5967804
DOI
10.1155/2022/5967804
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81904012]; Chongqing Province Natural Scientific Foundation [cstc2018jcyjAX0783, cstc2018jcyjAX0808, cstc2020jcyj-msxmX0036, cstc2019jxjl130007]

作者

  • S

    Song, Na (第一作者)

    chongqing hosp tradit chinese med

  • T

    Tu, Haitao

    1 · guangzhou univ chinese med

查看全部 10 位作者收起作者
  • L

    Li, Ying (通讯)

    chongqing hosp tradit chinese med

  • X

    Xiong, Weijian

    chongqing hosp tradit chinese med

  • Z

    Zhang, Ling

    chongqing hosp tradit chinese med

  • L

    Liu, Hong

    chongqing hosp tradit chinese med

  • D

    Ding, Weisen

    chongqing hosp tradit chinese med

  • L

    Long, Mei

    chongqing hosp tradit chinese med

  • R

    Ren, Dewei

    chongqing hosp tradit chinese med

  • Z

    Zhong, Jin

    chongqing hosp tradit chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417